Nephrotic syndrome associated with alpha interferon therapy in chronic myeloid leukemia.
Budak-Alpdoğan
T
T
Lawrence
R A
RA
Bayik
M
M
Akoğlu
E
E
D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D016898:Interferon-alpha / Q000009:adverse effects* / Q000627:therapeutic use; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D009404:Nephrotic Syndrome / Q000209:etiology*
D000970:Antineoplastic Agents; D016898:Interferon-alpha